Skip to content

Homeopathic treatment of sore throat

Effectiveness of Agraphis nutans in comparison to individualized homoeopathic medicines in treatment of Chronic Tonsillitis: An open-label randomised pragmatic equivalence trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016233
Enrollment
60
Registered
2018-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J350- Chronic tonsillitis and adenoiditis

Interventions

Intervention1: Agraphis nutans in centesimal potencies: It is planned as administering Agraphis nutans in centesimal potencies, as decided appropriate to the case or condition. In centesimal scale, ea
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP) certified firm. Along side, non-medicinal manageme
dosage and repetition depending upon the individual requirement of the cases. Along side, non-medicinal management like gurgling with lukewarm saline water twice a day will also be advised to every pa

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Three or more episodes of acute tonsillitis per year since last 2 years or patients with clinical sign and symptoms of chronic tonsillitis 2. Both female and male patients 3. Age range 18 -65 years 4. Literate patients; ability to read English/Bengali 5. Patients giving written consent to participate

Exclusion criteria

Exclusion criteria: 1. Presence of peritonsillar abscess or acute or chronic respiratory disease, occlusion of pharynx due to enlargement of tonsils 2. Severe co-morbidity including previous malignant disease during the past 5 years prior to enrolment 3. Previous surgery in the past 6 month or need for surgery of the nose, para-nasal sinuses, adenoid of tonsils. 4. Presence of neurological or psychiatric diseases affecting quality of life 5. Cases already undergoing homeopathic treatment for any chronic diseases 6. Treatment with systemic antibiotics, gluco-corticoids or immune modulators during the week prior to inclusion 7. Substance abuse and/or dependence 8. Patients not willing to give the consent 9. Pregnant and lactating women 10. Self-reported immune-compromised state

Design outcomes

Primary

MeasureTime frame
Three visual analogue scales in the sore throat pain model - sore throat pain intensity scale (STPIS), difficulty swallowing scale (DSS), and the swollen throat scale (swoTS)Timepoint: At baseline, after 6 weeks and 12 weeks

Secondary

MeasureTime frame
Glasgow benefit inventory scale measuring changes in quality of life during interventionTimepoint: After 6 weeks and 12 weeks;Tonsil and adenoid health status instrument (TAHSI) evaluating the quality of life of patients suffering from chronic tonsillitisTimepoint: At baseline, after 6 weeks and 12 weeks

Countries

India

Contacts

Public ContactUsha Ghelani Uchat

National Institute of Homoeopathy

dr.ushauchatnih2017@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 12, 2026